当前蛋白身份:P03040 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1COP THREE-DIMENSIONAL DIMER STRUCTURE OF THE LAMBDA-CRO REPRESSOR IN SOLUTION AS DETERMINED BY HETERONUCLEAR MULTIDIMENSIONAL NMR 提交 1995-06-23 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 D 1–66(66 aa)
链 E 1–66(66 aa)
未记录 未记录非水小分子 SOLUTION NMR mmCIF 未提供已读取条件 分辨率未提供
1D1L CRYSTAL STRUCTURE OF CRO-F58W MUTANT 提交 1999-09-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–61(61 aa) 片段:LAMBDA CRO REPRESSOR
突变:F58W SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;2.2 M NH4SO4, 6% isopropanol, including a layer of Hampton's "Al's oil", pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.K
分辨率 2.10 Å R-free 0.258
1D1L CRYSTAL STRUCTURE OF CRO-F58W MUTANT 提交 1999-09-17 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–61(61 aa) 片段:LAMBDA CRO REPRESSOR
突变:F58W SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;2.2 M NH4SO4, 6% isopropanol, including a layer of Hampton's "Al's oil", pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.K
分辨率 2.10 Å R-free 0.258
1D1L CRYSTAL STRUCTURE OF CRO-F58W MUTANT 提交 1999-09-17 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–61(61 aa) 片段:LAMBDA CRO REPRESSOR
突变:F58W SO4 SULFATE ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;2.2 M NH4SO4, 6% isopropanol, including a layer of Hampton's "Al's oil", pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298.K
分辨率 2.10 Å R-free 0.258
1D1M CRYSTAL STRUCTURE OF CRO K56-[DGEVK]-F58W MUTANT 提交 1999-09-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–60(60 aa) 片段:LAMBDA CRO REPRESSOR
链 B 1–60(60 aa) 片段:LAMBDA CRO REPRESSOR
突变:K56[DGEVK]-F58W 突变:K56[DGEVK]-F58W 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;298 K;4.8 M SODIUM FORMATE, 0.5% BETA-OCTYLGLUCOSIDE, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 2.05 Å R-free 0.298
1ORC CRO REPRESSOR INSERTION MUTANT K56-[DGEVK] 提交 1995-10-30 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–66(66 aa)
突变:INS(K56-DGEVK) 未记录非水小分子 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.54 Å
2A63 Solution structure of a stably monomeric mutant of lambda Cro produced by substitutions in the ball-and-socket interface 提交 2005-07-01 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–66(66 aa)
突变:A33W, F58D, Y26Q 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 5.3;293 K;离子强度(mmCIF原始值)no salt added;压力 ambient
NMR测量条件 pH 6.1;293 K;离子强度(mmCIF原始值)no salt added;压力 ambient
NMR测量条件 pH 6.1;298 K;离子强度(mmCIF原始值)no salt added;压力 ambient
NMR样品组成 2.5 mM lambda Cro A33W/F58D/Y26Q U-13C, 50mM Na-phosphate, 90% H2O, 10% D2O, 0.01% sodium azide, 1 mM TSP | 90% H2O/10% D2O
NMR样品组成 5 mM lambda Cro A33W/F58D/Y26Q U-15N, 50mM Na-phosphate, 90% H2O, 10% D2O, 0.01% sodium azide, 1 mM TSP | 90% H2O/10% D2O
NMR样品组成 5 mM lambda Cro A33W/F58D/Y26Q unlabelled, 50mM Na-phosphate, 90% H2O, 10% D2O, 0.01% sodium azide, 1 mM TSP | 90% H2O/10% D2O
NMR样品组成 5 mM lambda Cro A33W/F58D/Y26Q U-15N, 50mM Na-phosphate, 100% D2O, 0.01% sodium azide, 1 mM TSP | 100% D2O
分辨率未提供
2ECS Lambda Cro mutant Q27P/A29S/K32Q at 1.4 A in space group C2 提交 2007-02-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–66(66 aa)
链 B 1–66(66 aa)
突变:Q27P, A29S, K32Q 突变:Q27P, A29S, K32Q SO4 SULFATE ION × 4 ACT ACETATE ION × 4 CL CHLORIDE ION × 1 LI LITHIUM ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;80% saturated lithium sulfate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K
分辨率 1.40 Å R-free 0.175
2ECS Lambda Cro mutant Q27P/A29S/K32Q at 1.4 A in space group C2 提交 2007-02-14 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–66(66 aa)
链 B 1–66(66 aa)
突变:Q27P, A29S, K32Q 突变:Q27P, A29S, K32Q SO4 SULFATE ION × 8 ACT ACETATE ION × 8 CL CHLORIDE ION × 2 LI LITHIUM ION × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;80% saturated lithium sulfate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K
分辨率 1.40 Å R-free 0.175
2ORC CRO REPRESSOR INSERTION MUTANT K56-[DGEVK], NMR, 32 STRUCTURES 提交 1998-01-20 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–66(66 aa)
突变:INS(K56-DGEVK) 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 4.6;298 K
分辨率未提供
2OVG Lambda Cro Q27P/A29S/K32Q triple mutant at 1.35 A in space group P3221 提交 2007-02-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–66(66 aa)
突变:Q27P, A29S, K32Q SO4 SULFATE ION × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M lithium sulfate, 0.1 M Na Hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K
分辨率 1.35 Å R-free 0.171
2OVG Lambda Cro Q27P/A29S/K32Q triple mutant at 1.35 A in space group P3221 提交 2007-02-13 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–66(66 aa)
突变:Q27P, A29S, K32Q SO4 SULFATE ION × 1 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M lithium sulfate, 0.1 M Na Hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K
分辨率 1.35 Å R-free 0.171
2OVG Lambda Cro Q27P/A29S/K32Q triple mutant at 1.35 A in space group P3221 提交 2007-02-13 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–66(66 aa)
突变:Q27P, A29S, K32Q SO4 SULFATE ION × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M lithium sulfate, 0.1 M Na Hepes, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298.0K
分辨率 1.35 Å R-free 0.171
3ORC CRYSTAL STRUCTURE OF AN ENGINEERED CRO MONOMER BOUND NONSPECIFICALLY TO DNA 提交 1998-04-23 Assembly 1 蛋白–DNA 单体;蛋白 × 1 PDB 声明:trimeric(3) 与全部聚合物一致
链 A 2–61(60 aa)
突变:INSERTION (K56-DGEVK) 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;COCRYSTALS WERE OBTAINED BY MIXING A 1.5 MOLAR EXCESS OF THE 7BP DNA FRAGMENT WITH CRO K56-[DGEVK], COMBINING WITH AN EQUAL VOLUME OF PRECIPITANT BUFFER (140MM AMMONIUM ACETATE, 31% PEG 3350, 100MM ACETATE BUFFER PH 4.6), THEN EQUILIBRATING AGAINST THE PRECIPITANT BUFFER VIA THE HANGING-DROP METHOD AT ROOM TEMPERATURE., vapor diffusion - hanging drop, temperature 293K
分辨率 3.00 Å
4CRO PROTEIN-DNA CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURE OF A LAMBDA CRO-OPERATOR COMPLEX 提交 1992-01-15 Assembly 1 蛋白–DNA 同源多聚体;蛋白 × 2 PDB 声明:tetrameric(4) 与全部聚合物一致
链 A 1–66(66 aa)
链 B 1–66(66 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6.9;NA CACODYLATE, NACL, pH 6.90, VAPOR DIFFUSION
分辨率 3.90 Å
4CRO PROTEIN-DNA CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURE OF A LAMBDA CRO-OPERATOR COMPLEX 提交 1992-01-15 Assembly 2 蛋白–DNA 同源多聚体;蛋白 × 2 PDB 声明:tetrameric(4) 与全部聚合物一致
链 C 1–66(66 aa)
链 D 1–66(66 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6.9;NA CACODYLATE, NACL, pH 6.90, VAPOR DIFFUSION
分辨率 3.90 Å
4CRO PROTEIN-DNA CONFORMATIONAL CHANGES IN THE CRYSTAL STRUCTURE OF A LAMBDA CRO-OPERATOR COMPLEX 提交 1992-01-15 Assembly 3 蛋白–DNA 同源多聚体;蛋白 × 2 PDB 声明:tetrameric(4) 与全部聚合物一致
链 E 1–66(66 aa)
链 F 1–66(66 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6.9;NA CACODYLATE, NACL, pH 6.90, VAPOR DIFFUSION
分辨率 3.90 Å
5CRO REFINED STRUCTURE OF CRO REPRESSOR PROTEIN FROM BACTERIOPHAGE LAMBDA 提交 1998-04-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 B 1–66(66 aa)
链 O 1–66(66 aa)
未记录 PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 microdialysis or batch;pH 7.5;CRYSTALS WERE OBTAINED IN THE PRESENCE OF ABOUT 1.2M PHOSPHATE BY MICRODIALYSIS OR BATCH TECHNIQUES., pH 7.5, microdialysis or batch
分辨率 2.30 Å
5CRO REFINED STRUCTURE OF CRO REPRESSOR PROTEIN FROM BACTERIOPHAGE LAMBDA 提交 1998-04-17 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–66(66 aa)
链 C 1–66(66 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 microdialysis or batch;pH 7.5;CRYSTALS WERE OBTAINED IN THE PRESENCE OF ABOUT 1.2M PHOSPHATE BY MICRODIALYSIS OR BATCH TECHNIQUES., pH 7.5, microdialysis or batch
分辨率 2.30 Å
5CRO REFINED STRUCTURE OF CRO REPRESSOR PROTEIN FROM BACTERIOPHAGE LAMBDA 提交 1998-04-17 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 24 PDB 声明:24-meric(24) 与蛋白数一致
链 A 1–66(66 aa)
链 B 1–66(66 aa)
链 C 1–66(66 aa)
链 O 1–66(66 aa)
未记录 PO4 PHOSPHATE ION × 12 X-RAY DIFFRACTION
X-ray结晶条件 microdialysis or batch;pH 7.5;CRYSTALS WERE OBTAINED IN THE PRESENCE OF ABOUT 1.2M PHOSPHATE BY MICRODIALYSIS OR BATCH TECHNIQUES., pH 7.5, microdialysis or batch
分辨率 2.30 Å
5CRO REFINED STRUCTURE OF CRO REPRESSOR PROTEIN FROM BACTERIOPHAGE LAMBDA 提交 1998-04-17 Assembly 4 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 1–66(66 aa)
链 B 1–66(66 aa)
链 C 1–66(66 aa)
链 O 1–66(66 aa)
未记录 PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 microdialysis or batch;pH 7.5;CRYSTALS WERE OBTAINED IN THE PRESENCE OF ABOUT 1.2M PHOSPHATE BY MICRODIALYSIS OR BATCH TECHNIQUES., pH 7.5, microdialysis or batch
分辨率 2.30 Å
6CRO CRYSTAL STRUCTURE OF LAMBDA-CRO BOUND TO A CONSENSUS OPERATOR AT 3.0 ANGSTROM RESOLUTION 提交 1998-04-22 Assembly 1 蛋白–DNA 同源多聚体;蛋白 × 2 PDB 声明:hexameric(6) 与全部聚合物一致
链 A 2–61(60 aa)
未记录 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.9;293 K;CRO PROTEIN WAS SUSPENDED IN 20MM SODIUM CACODYLATE PH6.9 THEN MIXED WITH A 30% EXCESS OF THE 19BP DNA FRAGMENT. THE COMPLEX WAS THEN MIXED WITH AN EQUAL VOLUME OF PRECIPITANT SOLUTION (70MM AMMONIUM SULFATE, 13% PEG3350) AND ALLOWED TO EQUILIBRATE VIA THE HANGING DROP METHOD AT ROOM TEMPERATURE. COCRYSTALS TYPICALLY TAKE 3-4 MONTHS TO APPEAR., vapor diffusion - hanging drop, temperature 293K
分辨率 3.00 Å